학술논문
NICE should reconsider guidance on inclisiran: Recommendation is premature without data on cardiovascular outcomes.
Document Type
Article
Author
Source
BMJ: British Medical Journal; 10/23/2021, Vol. 375 Issue 8311, pn2462-n2462, 1p
Subject
Language
ISSN
17561833